In the spirit of “radical collaboration”, the Journal of Business and Intellectual Property Law (JBIPL), has chosen to focus its spring symposium on Regenerative Healthcare and the Law. The Wake Forest Institute of Regenerative Medicine (WFIRM) is home to the largest regenerative medicine facility in the world, making Winston-Salem the perfect place for us to identify and discuss three subtopics through interactive panels that will focus on: (1) the FDA’s Role in Regenerative Healthcare; (2) Bioethics and the Law in Regenerative Healthcare; and (3) Going to Market and the Future of Business in Regenerative Medicine. The symposium will encompass frank and insightful discussions on each subtopic while emphasizing the role and prevalence of regenerative healthcare at large; a topic that needs to be further researched, scrutinized and debated amongst students and professors alike.